Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Family Medicine
Disease Category: Alzheimer's Disease
Location: United States, CA

Clinical Trial Details

Overview

Research Study Summary

Alzheimers? Be a Part of Research.

Purpose

This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline of Alzheimer's disease as compared with placebo (a substance that looks like the study drug, but has no medicine).

Qualified Participants Must: Be diagnosed with a mild to moderate form of Alzheimer's disease; Have a reliable caregiver who is in frequent contact with you; Have good veins

Qualified Participants Will Receive: $50 per completed study visit.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Compensation

$50 and up

Contact

Apex Research Institute
999 N. Tustin Ave., #120
Santa Ana, CA 92705
Phone: 714-542-3008

View Map

CW ID: 157013

Date Last Changed: July 24, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.